Literature DB >> 7538373

Degradation of kinins, angiotensins and substance P by polymorphonuclear matrix metalloproteinases MMP 8 and MMP 9.

O Diekmann1, H Tschesche.   

Abstract

1. The kinetics of the degradation of the kinins bradykinin and Met-Lys-bradykinin, angiotensins I and II and the tachykinin substance P by PMNL-collagenase (MMP 8), PMNL-gelatinase (MMP 9) and by the recombinant catalytic domain of MMP 8 (rcd-PMNL-c) was examined by RP-HPLC. The resulting fragments were identified by automated Edman degradation or by amino acid analysis. 2. The initial degradation rates of substance P at a substrate concentration of 25 microM were 5 min-1 for MMP 9 and 150 min-1 for MMP 8. The kinetic constants KM and kcat were determined by concentration-dependent measurements. For MMP 8/substance P the constants were KM = 78 +/- 14 microM and kcat = 412 +/- 67 min-1. For MMP 9/substance P the constants were KM = 91 +/- 15 microM and kcat = 25 +/- 4 min-1. Both enzymes cleaved substance P between Gln6 and Phe7 and between Gly9 and Leu10. 3. Under the same conditions, MMP 8 degraded angiotensin I at an initial rate of 20 h-1, resulting mainly in the vasoactive fragments angiotensin II and angiotensin(1-7). At a substrate concentration of 25 microM and an enzyme/substrate ratio of 1:100, angiotensin II was degraded very slowly (19% in 24 h) by MMP 8. Under these conditions, MMP 9 degraded angiotensin I to a lesser extent than MMP 8 (25% in 24 h) and was unable to cleave angiotensin II. 4. Under the same conditions, bradykinin and Met-Lys-bradykinin were cleaved by PMNL-collagenase at a rate of 20% in 24 h, producing BK(1-7) and BK(1-8). PMNL-gelatinase was unable to cleave the kinins under these conditions. 5. In all cases, rcd-PMNL-c produced the same fragments as wild type PMNL-collagenase, but at a significantly lower rate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7538373

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  13 in total

1.  ACE inhibitors to block MMP-9 activity: new functions for old inhibitors.

Authors:  Yufang Jin; Hai-Chao Han; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2007-09-12       Impact factor: 5.000

2.  Concentration dependent effects of fibroblast-like synoviocytes on collagen gel multiscale biomechanics & neuronal signaling: Implications for modeling human ligamentous tissues.

Authors:  Meagan Ita; Beth A Winkelstein
Journal:  J Biomech Eng       Date:  2019-06-18       Impact factor: 2.097

Review 3.  MMP induction and inhibition in myocardial infarction.

Authors:  Merry L Lindsey
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

4.  Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata.

Authors:  Thibaut Quillard; Haniel Alves Araújo; Gregory Franck; Yevgenia Tesmenitsky; Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04-10       Impact factor: 8.311

5.  Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery.

Authors:  Niyanta N Kumar; Jeffrey J Lochhead; Michelle E Pizzo; Geetika Nehra; Sam Boroumand; Gretchen Greene; Robert G Thorne
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

6.  Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice.

Authors:  Pablo A Quintero; Martin D Knolle; Luisa F Cala; Yuehong Zhuang; Caroline A Owen
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

7.  MMP-8 promotes polymorphonuclear cell migration through collagen barriers in obliterative bronchiolitis.

Authors:  Umakanth A Khatwa; Bjoern E Kleibrink; Steven D Shapiro; Meera Subramaniam
Journal:  J Leukoc Biol       Date:  2009-10-02       Impact factor: 4.962

8.  A role of matrix metalloproteinase-8 in atherosclerosis.

Authors:  Ross C Laxton; Yanhua Hu; Johan Duchene; Feng Zhang; Zhongyi Zhang; Kit-Yi Leung; Qingzhong Xiao; Ramona S Scotland; Conrad P Hodgkinson; Katherine Smith; Johann Willeit; Carlos López-Otín; Iain A Simpson; Stefan Kiechl; Amrita Ahluwalia; Qingbo Xu; Shu Ye
Journal:  Circ Res       Date:  2009-09-10       Impact factor: 17.367

9.  Proteolysis controls endogenous substance P levels.

Authors:  Andrew J Mitchell; Anna Mari Lone; Arthur D Tinoco; Alan Saghatelian
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

10.  Substance P and Acute Pain in Patients Undergoing Orthopedic Surgery.

Authors:  Barbara Lisowska; Katarzyna Siewruk; Aleksander Lisowski
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.